PTGS2 and neoplasm: Studies have shown that mice harboring transgenic overexpression of cox-2 in the stomach [44] and skin [45] are highly prone to develop tumors in these organs, whereas genetic ablation of cox-2 protects mice against gastro-intestinal [46] and skin carcinogenesis [47].